AlphaRX (OTC:ALRX) Terminates Chief Scientist and Chief Medical Officer
Posted on June 01, 2011 at 17:57 PM EDT
Oxford, MS 6/1/2011 (PennyPayDay) --  AlphaRx Inc. (OTC:ALRX) announced today, in a press release, that the Board of Directors of the Company has terminated Dr.  Joseph Schwarz  and Dr.  Michael Weisspapir , the Chief Scientist and the Chief Medical Officer of the Company respectively, for violations of the Company's policies and procedures. The Company has reserved any and all legal recourse against Drs. Schwarz and Weisspapir. The Company also announced that it will promptly begin a search for a new Chief Scientist. AlphaRx is a specialty pharmaceutical company utilizing proprietary drug delivery systems to develop novel formulations of drugs that are insoluble or poorly soluble in water or have yet to be administrable to the human body with an acceptable delivery method. Distributed by IntelBuilder Social Media Platform
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here